MONTELUKAST SODIUM
- Product NDC
- 69844-040
- 11-digit product format
- 698440040
- Labeler code
- 69844
- Product ID
- 69844-040_4d266794-eeb8-4897-a9c1-6d18dfe5548e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MONTELUKAST SODIUM
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Labeler
- Graviti Pharmaceuticals Private Limited
- Application
- ANDA209011
- Marketing category
- ANDA
- Marketing start
- 2020-04-06
- Marketing end
- 0000-00-00
- Substance
- MONTELUKAST SODIUM
- Active strength
- 5 mg/1
- Pharmacologic classes
- Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69844-040-01 | 69844004001 | 30 TABLET, CHEWABLE in 1 BOTTLE (69844-040-01) | 2020-04-06 | 0000-00-00 | No | No | Current |
| 69844-040-02 | 69844004002 | 100 TABLET, CHEWABLE in 1 BOTTLE (69844-040-02) | 2020-04-06 | 0000-00-00 | No | No | Current |